Cutler Group’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Cutler Group’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-500	Closed	-$24K	–	5200
2020 Q1	$24K	Sell	500 -500	-50%	-$23.3K	﹤0.01%	2190
2019 Q4	$46K	Buy	+1,000	New	+$44.2K	﹤0.01%	1684
2019 Q2	–	Sell	-300	Closed	-$6K	–	5075
2019 Q1	$6K	Buy	+300	New	+$6.45K	﹤0.01%	2863

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Cutler Group's RARX Position: Q2 2020 in Review

Cutler Group sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 500 shares — an estimated $24K sold.

Cutler Group first reported a position in RARX in Q1 2019 and held it in 3 quarters. The position peaked at $46K in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Cutler Group reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Cutler Group sold 500 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $24K.
Cutler Group first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Cutler Group's Ra Pharmaceuticals, Inc. Common Stock position peaked at $46K in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Cutler Group's 13F filing for Q2 2020, filed 22 Jul 2020.